A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2011
11/07/2011	CA2739626A1 Non-glycosylated transferrin expressed in monocots
11/05/2011	CA2778690A1 Antibody mimetic scaffolds
11/03/2011	WO2011137334A1 Compositions and methods for stimulating immune response against moraxella catarrhalis
11/03/2011	WO2011137319A2 Stabilized fibronectin domain compositions, methods and uses
11/03/2011	WO2011136828A1 Immunogenic compositions and methods for treating neoplasia
11/03/2011	WO2011136744A1 Eif4e binding peptides
11/03/2011	WO2011136469A2 Pharmaceutical composition using connective tissue growth factor
11/03/2011	WO2011136378A1 Grafting material for genetic and cell therapy
11/03/2011	WO2011136361A1 Peptide for improving in vivo stability of physiologically active substance or the like and physiologically active substance with improved in vivo stability
11/03/2011	WO2011136313A1 High-purity soluble thrombomodulin and method for producing same
11/03/2011	WO2011136233A1 Self-renewal promoter for neural stem cells and method for using same
11/03/2011	WO2011136174A1 Depsipeptide compound
11/03/2011	WO2011135308A1 Conjugated blood coagulation factor viia
11/03/2011	WO2011135307A1 Conjugated blood coagulation factor viii
11/03/2011	WO2011135304A1 Ncam-vase and neuroregeneration
11/03/2011	WO2011135253A1 Polypeptide expressed in the stratum corneum and use thereof
11/03/2011	WO2011134979A2 Stable mia/cd-rap formulation
11/03/2011	WO2011134809A1 Enzyme granules
11/03/2011	WO2011134471A1 Peptide conjugates of glp-1 receptor agonists and gastrin and their use
11/03/2011	WO2011134284A1 Glucagon-like peptide-1 analogue and use thereof
11/03/2011	WO2011134084A1 Methods, compositions, and kits for the treatment of matrix mineralization disorders
11/03/2011	WO2011134075A1 Sox9 inhibitors
11/03/2011	WO2011134063A1 Ccn3 and uses thereof against metabolic syndrome- associated disorders
11/03/2011	WO2011134056A1 Methods and uses of tie2 binding and/or activating agents
11/03/2011	WO2011134026A1 Cosmetic methods and compositions
11/03/2011	WO2011134023A1 Inhibition of glioma
11/03/2011	WO2011089225A9 Use of aprotinin for treating parasitic infections and prognosing bovine trypanotolerance
11/03/2011	WO2011082087A3 Dps fusion proteins for use in vaccines and diagnostics
11/03/2011	WO2011077359A3 Synergic action of a prolyl protease and tripeptidyl proteases
11/03/2011	WO2011075606A3 Hyperglycosylated polypeptide variants and methods of use
11/03/2011	WO2011072266A3 Aminoacyl trna synthetases for modulating hematopoiesis
11/03/2011	WO2011066453A3 Pacap and related proteins in the treatment of cancer
11/03/2011	WO2011066378A3 Antagonists of il-6 to prevent or treat thrombosis
11/03/2011	WO2011066285A3 Peptide-based treatment for neurodegenerative diseases
11/03/2011	WO2011063320A3 Recombinant filaggrin polypeptides for cell importation
11/03/2011	WO2011056033A3 Pharmaceutical composition for preventing / treating trpv1 activity-related and inflammation-related diseases or conditions containing maillard peptide separated from well-aged traditional soy sauce as active ingredient
11/03/2011	WO2011049914A3 Anti-hiv peptides and methods of use thereof
11/03/2011	WO2011047183A3 Use of a neuregulin to treat peripheral nerve injury
11/03/2011	WO2011044082A3 Compositions and methods for inhibiting madcam
11/03/2011	WO2011026132A8 Methods and compositions for the inhibition of transplant rejection
11/03/2011	WO2011020117A3 Methods of treating cancer using neurotrophin retargeted endopeptidases
11/03/2011	US20110271357 Colon disease targets and uses thereof
11/03/2011	US20110271356 Hcv entry factor, occludin
11/03/2011	US20110270215 composition comprising nor-adrenaline and a net inhibitor for administering to a brain-dead, heart-beating potential organ donor
11/03/2011	US20110270212 Pharmacokinetic control for optimized interferon delivery
11/03/2011	US20110269950 PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
11/03/2011	US20110269947 Apo-2 ligand/trail formulations
11/03/2011	US20110269703 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy
11/03/2011	US20110269699 Cancer therapy
11/03/2011	US20110269698 Novel Cyclic Pentadepsipeptide Derivative and Fusarium Strain Producing The Same
11/03/2011	US20110269697 Organoarsenic compounds and methods for the treatment of cancer
11/03/2011	US20110269696 Inhibitors of iaps
11/03/2011	US20110269695 Novel anti-aging peptides and cosmetic and/or pharmaceutical composition containing same
11/03/2011	US20110269694 Novel anti-aging peptides and cosmetic and/or pharmaceutical composition containing same
11/03/2011	US20110269693 Apparatus for treatment of dermatological conditions
11/03/2011	US20110269692 Alpha-fetoprotein peptides and uses thereof
11/03/2011	US20110269691 Compositions and Methods for Treating Pigmentary Conditions and Melanoma
11/03/2011	US20110269690 Water-mediated control of depolymerization step of glatiramer acetate synthesis
11/03/2011	US20110269689 High penetration compositions and their applications
11/03/2011	US20110269688 Genetic Alterations Associated with Schizophrenia and Methods of Use Thereof for the Diagnosis and Treatment of the Same
11/03/2011	US20110269687 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants
11/03/2011	US20110269686 Cxcr4 antagonist and use thereof
11/03/2011	US20110269685 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
11/03/2011	US20110269684 Natriuretic polypeptides for reducing or preventing restenosis
11/03/2011	US20110269683 Receptor(sstr2)-selective somatostatin antagonists
11/03/2011	US20110269682 Compositions and Methods for Treatment During Non-Acute Periods Following CNS Neurological Injury
11/03/2011	US20110269681 Prolactin Induced Increase in Neural Stem Cell Numbers
11/03/2011	US20110269680 Glp-1 analogs and uses thereof
11/03/2011	US20110269679 Inhibitors of amyloid fibril formation and uses thereof
11/03/2011	US20110269678 Nutritional method
11/03/2011	US20110269677 Oligomer-Protease Inhibitor Conjugates
11/03/2011	US20110269676 Bifunctional molecules for inactivating hiv and blocking hiv entry
11/03/2011	US20110269675 Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
11/03/2011	US20110269674 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
11/03/2011	US20110269673 Antimicrobial Peptides
11/03/2011	US20110269671 Nisin derivatives and the use thereof
11/03/2011	US20110269670 Carbohydrate binding molecules
11/03/2011	US20110269669 Self-decontaminating coatings containing antimicrobial peptides
11/03/2011	US20110269668 Fused Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors
11/03/2011	US20110269667 Methods of generating and using procollagen
11/03/2011	US20110269666 Method and drug composition for treating septic shock hypotension
11/03/2011	US20110269665 Compound and method for treating myotonic dystrophy
11/03/2011	US20110269227 Peptide having bindability with adiponectin, analysis method utilizing same peptide, and analysis device utilizing same peptide
11/03/2011	US20110269146 Expression Vectors and Cell Lines Expressing Vascular Endothelial Growth Factor D, and Method of Treating Melanomas
11/03/2011	US20110269122 Hereditary hemochromatosis gene
11/03/2011	US20110268970 Mesoporous nanoparticles
11/03/2011	US20110268820 Use of selective estrogen receptor modulator for joint fusion and other repair or healing of connective tissue
11/03/2011	US20110268818 Ngal-binding siderophores and use thereof to treat iron deficiency and iron overload
11/03/2011	US20110268807 Biodegradable Microspheres and Methods of Use Thereof
11/03/2011	US20110268805 Adjuvant incorporation in immunonanotherapeutics
11/03/2011	US20110268795 Compositions and methods for inducing satiety and treating non-insulin dependent diabetes mellitus, prediabetic symptoms, insulin resistance and related disease states and conditions
11/03/2011	US20110268791 Porous nanoparticle supported lipid bilayer nanostructures
11/03/2011	US20110268790 Snake Factor V and Methods of Use Thereof as a Procoagulant
11/03/2011	US20110268789 Use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs as adjunctive treatments with anticancer agents
11/03/2011	US20110268775 Nanoparticle pharmaceutical formulations
11/03/2011	US20110268773 Inclusion bodies, bacterial cells and compositions containing them and uses thereof
11/03/2011	US20110268769 Drug delivery vehicle for cancer therapy, process for producing the same, and pharmaceutical preparation using the same
11/03/2011	US20110268768 Compositions and Methods for Treating Atherosclerosis
11/03/2011	US20110268759 Novel anti-stretch mark active agent, and compositions containing same
11/03/2011	US20110268755 Survivin Peptides For Autoimmune Therapies

1 ... 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 ... 3163